Cost benefit and clinical efficacy of low-dose granulocyte colony-stimulating factor after standard chemotherapy in patients with non-Hodgkin's lymphoma.
Hashino S, Morioka M, Irie T, Shiroshita N, Kawamura T, Suzuki S, Iwasaki H, Umehara S, Kakinoki Y, Kurosawa M, Kahata K, Izumiyama K, Kobayashi H, Onozawa M, Takahata M, Fujisawa F, Kondo T, Asaka M.
Hashino S, et al.
Int J Lab Hematol. 2008 Aug;30(4):292-9. doi: 10.1111/j.1751-553X.2007.00955.x.
Int J Lab Hematol. 2008.
PMID: 18665826
Clinical Trial.